These isotypes were screened together with Ki67 expression prior to- (pre-chemo) and after neoadjuvant chemotherapy (post-chemo) using whole-slide immunofluorescence digital microscopy in 96 breast cancers included in tissue microarrays (TMA). This evidence concerns the gene MKI67 and breast cancer.